InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the complete record of transactions filed by Glanzman Robert, Directeur Médical. Director active across 1 companies, notably Clene Inc.. Cumulatively, 3 reports have been recorded. Total volume traded: €9k. The latest transaction was disclosed on 16 May 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
€9,1734,717 shares@ €1.94460.014% mcap100.0% of flow
Common Stock
SEC:0001562180-22-004174:0·
015,281 shares0
Common Stock
SEC:0001562180-21-004607·
015,281 shares0
Common Stock
SEC:0001562180-21-004607:0·
3 of 3 declarations
About Glanzman Robert
Glanzman Robert serves as Chief Medical Officer at Clene Inc. In this role, he is responsible for the company's medical strategy and research initiatives. His expertise in the medical field enables him to lead teams in developing new treatments. He plays a crucial role in guiding Clene's research and development efforts.
